Analysts Shrug at Stock Selloff Following CVS Earnings Report
Although CVS Health Corp.’s stock price dropped about 5% after the company reported its fourth-quarter and full-year 2020 financial results on Feb. 16, equities analysts seemed to be unshaken in their view that the firm — which owns health insurer Aetna — has strong fundamentals.
For the fourth quarter of 2020, CVS’s net income of $975 million was down 44% compared with the prior-year period, a result the company partially attributed to lower operating income driven by the impact of the COVID-19 pandemic on its Health Care Benefits and Retail/Long-Term Care segments. For the full year 2020, CVS’s operating income and net income increased relative to 2019, fueled in part by a $307 million payout from the Affordable Care Act’s risk corridors program and a $269 million gain from the sale of the firm’s workers’ compensation business.
Related Posts

Humana Anticipates Strong EPS Growth in 2023, Cites Individual MA Enrollment Increase
READ MORE
Study Could Help Policymakers Set Fair Reimbursement Rate for Ground Ambulances
READ MORE